Table 3.

Malaria prevalence and parasite density among the PLHIV.

	INFECTED, % (n/N)	P	PARASITEMIA [IQR]	P
Age		0.15		0.03
<25 years	14.6 (6/41)		2810 [30–2577]
25–54 years	6.6 (43/652)		173 [44–1264]
≥55 years	7.8 (12/153)		14 [7–36]
Sex		0.50		<0.01
Female	7.5 (43/570)		183 [21–1400]
Male	6.3 (18/286)		53 [8–234]
Education level		0.67		0.03
None or primary	7.1 (10/141)		5600 [5600–7700]
Secondary	5.1 (20/393)		53 [7–77]
High	5.9 (11/185)		7 [5–77]
Bednet use		<0.01		0.08
Yes	9.7 (20/207)		147 [12–1195]
No	4.1 (18/437)		77 [12–2345]
Previous antimalarial treatment		0.72		0.04
Yes	8.6 (3/35)		8 [4–23]
No	5.6 (44/779)		77 [14–1400]
ART use		0.25		–
1st line	6.9 (40/576)		105 [14–764]
2nd line	1.6 (1/64)		–
No	6.9 (8/116)		112 [14–1508]
Cotrimoxazole use		0.02		0.19
Yes	4.1 (13/320)		70 [18–1332]
No	8.3 (43/515)		65 [14–764]
Anemia		0.26		0.46
Yes	5.3 (11/207)		147 [18–2345]
No	3.2 (9/277)		28 [18–92]
CD4 cell (number/µL)		0.73		0.03
<200	5.9 (9/153)		773 [14–5180]
200–499	4.6 (10/219)		219 [101–745]
≥500	4.0 (6/149)		77 [45–705]

^*Calculated among patients with available data (see Table 1).